Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1985 Jun;51(6):877–882. doi: 10.1038/bjc.1985.133

Immunoreactive inhibin-like material in serum and gastric juice of patients with benign and malignant diseases of the stomach.

S A Shanbhag, A R Sheth, S A Nanivadekar, N A Sheth
PMCID: PMC1977073  PMID: 4005143

Abstract

Immunoreactive inhibin-like material (ILM) was measured by radioimmunoassay (RIA) in serum and gastric juice samples of 23 fasting normal men, 27 men with chronic superficial gastritis (CSG), and 21 men with carcinoma of stomach (5 for gastric analysis). Serum ILM levels in carcinoma of stomach patients (367 +/- 55.5 ng ml-1) were significantly higher than in normal men (15.4 +/- 2.6 ng ml-1; P less than 0.01) and in patients with CSG (109.8 +/- 17.7 ng ml-1; P less than 0.05). Sixty two per cent and 86% of patients with carcinoma of stomach showed elevated ILM levels which were higher than the highest noted in patients with CSG and normal men respectively.

Full text

PDF
877

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bagshawe K. D. Third Gordon Hamilton-Fairley Memorial Lecture. Tumour markers--where do we go from here? Br J Cancer. 1983 Aug;48(2):167–175. doi: 10.1038/bjc.1983.172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Deo M. G., Mulherkar R., Mane S. M. Isolation of a polypeptide that enhances cellular binding of epidermal growth factor. Indian J Biochem Biophys. 1983 Aug;20(4):228–231. [PubMed] [Google Scholar]
  3. Elsborg L., Mosbech J. Pernicious anaemia as a risk factor in gastric cancer. Acta Med Scand. 1979;206(4):315–318. doi: 10.1111/j.0954-6820.1979.tb13517.x. [DOI] [PubMed] [Google Scholar]
  4. GREENWOOD F. C., HUNTER W. M., GLOVER J. S. THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. Biochem J. 1963 Oct;89:114–123. doi: 10.1042/bj0890114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ihamäki T., Saukkonen M., Siurala M. Long-term observation of subjects with normal mucosa and with superficial gastritis: results of 23--27 years' follow-up examinations. Scand J Gastroenterol. 1978;13(7):771–775. doi: 10.3109/00365527809182189. [DOI] [PubMed] [Google Scholar]
  6. Johansson J., Sheth A., Cederlund E., Jörnvall H. Analysis of an inhibin preparation reveals apparent identity between a peptide with inhibin-like activity and a sperm-coating antigen. FEBS Lett. 1984 Oct 15;176(1):21–26. doi: 10.1016/0014-5793(84)80904-7. [DOI] [PubMed] [Google Scholar]
  7. Moodbidri S. B., Vaze A. Y., Sheth A. R. Measurement of inhibin. Arch Androl. 1980 Dec;5(4):295–303. doi: 10.3109/01485018008986999. [DOI] [PubMed] [Google Scholar]
  8. Seidah N. G., Arbatti N. J., Rochemont J., Sheth A. R., Chrétien M. Complete amino acid sequence of human seminal plasma beta-inhibin. Prediction of post Gln-Arg cleavage as a maturation site. FEBS Lett. 1984 Oct 1;175(2):349–355. doi: 10.1016/0014-5793(84)80766-8. [DOI] [PubMed] [Google Scholar]
  9. Shanbhag S. A., Sheth A. R., Nanivadekar S. A., Sheth N. A. Studies on inhibin-like peptide in gastric juice and serum of patients with duodenal ulcers. J Endocrinol. 1984 Dec;103(3):389–393. doi: 10.1677/joe.0.1030389. [DOI] [PubMed] [Google Scholar]
  10. Sheth A. R., Arabatti N., Carlquist M., Jörnvall H. Characterization of a polypeptide from human seminal plasma with inhibin (inhibition of FSH secretion)-like activity. FEBS Lett. 1984 Jan 2;165(1):11–15. doi: 10.1016/0014-5793(84)80004-6. [DOI] [PubMed] [Google Scholar]
  11. Sheth N. A., Adil M. A., Shinde S. R., Sheth A. R. Paraendocrine behaviour of tumours of the gastrointestinal tract with reference to human placental lactogen. Br J Cancer. 1980 Oct;42(4):610–612. doi: 10.1038/bjc.1980.285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Sheth N. A., Hurkadli K. S., Sathe V. S., Sheth A. R. Circulating levels of inhibin in cancer. Neoplasma. 1984;31(3):315–321. [PubMed] [Google Scholar]
  13. Sheth N. A., Vaze A. Y., Sheth A. R. A peptide in gastric secretion with inhibin-like properties. Clin Endocrinol (Oxf) 1982 Aug;17(2):157–163. doi: 10.1111/j.1365-2265.1982.tb01574.x. [DOI] [PubMed] [Google Scholar]
  14. Shinde S. R., Adil M. A., Sheth A. R., Koppikar M. G., Sheth N. A. Ectopic human placental lactogen and beta-human chorionic gonadotropin in gastric fluid of patients with malignant and non-malignant conditions of the stomach. Oncology. 1981;38(5):277–280. doi: 10.1159/000225570. [DOI] [PubMed] [Google Scholar]
  15. Sipponen P., Kekki M., Siurala M. Age-related trends of gastritis and intestinal metaplasia in gastric carcinoma patients and in controls representing the population at large. Br J Cancer. 1984 Apr;49(4):521–530. doi: 10.1038/bjc.1984.80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Siurala M., Salmi H. J. Long-term follow-up of subjects with superficial gastritis or a normal gastric mucosa. Scand J Gastroenterol. 1971;6(5):459–463. doi: 10.3109/00365527109180726. [DOI] [PubMed] [Google Scholar]
  17. Vijayalakshmi S., Sheth P. R., Dandekar S. P., Vaze A. Y., Moodbidri S. B., Sheth A. R. Biological studies with low and high molecular weight inhibin preparations. Int J Androl. 1981 Dec;4(6):691–702. doi: 10.1111/j.1365-2605.1981.tb00753.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES